Citation: | LI Binbin, HU Liqun, TAN Meihua, LAI Feimin. Effect observation of conbercept combined with atorvastatin in the treatment of hyperlipidemia complicated with diabetic macular edema[J]. Journal of Clinical Medicine in Practice, 2020, 24(22): 41-43. DOI: 10.7619/jcmp.202022011 |
KAHNERT K, LUCKE T, HUBER R M, et al. Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort[J]. PLoS One, 2017, 12(5): e0177501.
|
MATOGA M M, HOSSEINIPOUR M C, AGA E, et al. Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings[J]. Antivir Ther, 2017, 22(3): 205-213.
|
丁国鹏, 丁国龙, 雷姝, 等. 康柏西普联合577nm微脉冲激光治疗糖尿病性黄斑水肿临床观察[J]. 国际眼科杂志, 2015, 15(11): 1942-1944.
|
THEODOSIS-NOBELOS P, PAPAGIOUVANNIS G, KOUROUNAKIS P N, et al. Active anti-inflammatory and hypolipidemic derivatives of lorazepam[J]. Molecules, 2019, 24(18): E3277-E3283.
|
孙清磊, 罗媛媛, 宋颖, 等. 糖尿病性黄斑水肿的发病机制与治疗进展[J]. 中华老年多器官疾病杂志, 2015, 14(1): 33-38.
|
郭永兰, 赵亮亮, 聂黎黎, 等. 糖尿病性黄斑水肿的发病机制及治疗进展[J]. 国际老年医学杂志, 2019, 40(2): 116-119.
|
唐孟苏, 张淑琦, 马立威. 曲安奈德球周注射联合阈下值微脉冲激光对糖尿病性黄斑水肿的疗效观察[J]. 中国实用眼科杂志, 2018, 36(5): 364-367.
|
姜林, 杨红, 张世慧. 曲安奈德玻璃体腔注射联合视网膜激光光凝术在糖尿病黄斑水肿患者中的临床应用及安全性评价[J]. 实用临床医药杂志, 2017, 21(5): 167-169.
|
李文清, 宋艳萍, 丁琴. 康柏西普联合577 nm阈值下微脉冲激光光凝治疗糖尿病黄斑水肿的疗效观察[J]. 中华眼底病杂志, 2019, 35(2): 129-134.
|
DEMIR V, DO?RU M T, EDE H, et al. The effects of treatment with atorvastatin versus rosuvastatin on endothelial dysfunction in patients with hyperlipidaemia[J]. Cardiovasc J Afr, 2018, 29(3): 162-166.
|
王海山, 张海军, 李玉军, 等. 雷珠单抗玻璃体腔注射并激光光凝治疗糖尿病性黄斑水肿疗效观察[J]. 中国实用眼科杂志, 2015, 33(1): 25-29.
|
张召弟, 郭晟, 李娟, 等. 康柏西普和雷珠单抗治疗弥漫性糖尿病性黄斑水肿的疗效比较[J]. 广西医学, 2018, 40(5): 500-502
, 517.
|